Live Chat

FDA’s Rigorous Review Demonstrates Concern about Risk

Earlier this year, the Food and Drug Administration (FDA), long concerned about the risks associated with transvaginal mesh implants, requested information from 35 transvaginal mesh manufacturers regarding the safety and effectiveness of this dangerous medical device. In particular, the FDA is concerned – as are a large and growing number of patients and health care providers – that post-surgical vaginal complications are linked to this commonly prescribed surgical implant.

 

Have you or your loved one experienced physical pain, emotional suffering, or medical and financial costs because of a transvaginal mesh complication? If so, the time to act is now and the people to call are the attorneys at Fears Nachawati. With years of experience helping victims, we know how to fight for transvaginal mesh patients. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Categories
Drug Litigation

FDA’s Rigorous Review Demonstrates Concern about Risk